Clinical reference
Antituberculous agent · First-line antituberculous drug · Infectious Disease, Pulmonology, Pediatrics
Pyrazinamide is a first-line antituberculous agent used as part of multidrug regimens for the treatment of active tuberculosis. It is bactericidal against Mycobacterium tuberculosis under acidic conditions and is typically given in combination with isoniazid and rifampin during the intensive phase of therapy. It is available as 500 mg tablets and 100 mg/m…